TickerFacts.

Personalis, Inc. (PSNL): Free Cash Flow

Operating cash flow minus capital expenditures for the same annual period and currency, computed by TickerFacts from the filed figures. A simple proxy, not a reported figure; a year without both inputs is left out.

-$79.45M
Year ended 2025-12-31
-$100.97M
Trailing 12 months to 2026-06-30
2017-12-31: -$4.87M2018-12-31: -$2.28M2019-12-31: -$26.45M2020-12-31: -$45.90M2021-12-31: -$81.91M2022-12-31: -$120.13M2023-12-31: -$67.17M2024-12-31: -$46.75M2025-12-31: -$79.45M-$79.45M
2017-12-31 Free Cash Flow (USD) 2025-12-31
Period endedFree Cash FlowChange YoYSource filing
2025-12-31-$79.45Mn/m2026-02-26, From 2025-01-01
2024-12-31-$46.75Mn/m2026-02-26, From 2024-01-01
2023-12-31-$67.17Mn/m2025-02-27, From 2023-01-01
2022-12-31-$120.13Mn/m2024-02-28, From 2022-01-01
2021-12-31-$81.91Mn/m2024-02-28, From 2021-01-01
2020-12-31-$45.90Mn/m2023-02-23, From 2020-01-01
2019-12-31-$26.45Mn/m2022-02-24, From 2019-01-01
2018-12-31-$2.28Mn/m2021-02-25, From 2018-01-01
2017-12-31-$4.87Mn/a2020-03-25, From 2017-01-01

Free Cash Flow at similar companies

Companies with the same SEC industry code (Services-Medical Laboratories), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedFree Cash FlowChange YoY
Personalis, Inc. (PSNL)2025-12-31-$79.45Mn/m
Exagen Inc. (XGN)2025-12-31-$14.27Mn/m
Biodesix Inc (BDSX)2025-12-31-$23.53Mn/m
GRAIL, Inc. (GRAL)2025-12-31-$299.92Mn/m
American Shared Hospital Services (AMS)2025-12-31-$4.54Mn/m
BillionToOne, Inc. (BLLN)2025-12-31$15.71Mn/m
Fulgent Genetics, Inc. (FLGT)2025-12-31-$124.21Mn/m
Castle Biosciences Inc (CSTL)2025-12-31$28.33M-22.5%
Veracyte, Inc. (VCYT)2025-12-31$126.63M+98.5%

Compare PSNL, XGN, BDSX, GRAL side by side · Screen every company in Services-Medical Laboratories ↗